Valeria Antoncecchi

ORCID: 0009-0009-7382-3247
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal and Vascular Pathologies
  • Blood Pressure and Hypertension Studies
  • Dialysis and Renal Disease Management
  • Cardiovascular Function and Risk Factors
  • Hemodynamic Monitoring and Therapy
  • Chronic Kidney Disease and Diabetes
  • COVID-19 Clinical Research Studies
  • Pulmonary Hypertension Research and Treatments
  • Heart Failure Treatment and Management
  • Cardiac pacing and defibrillation studies
  • Long-Term Effects of COVID-19
  • Galectins and Cancer Biology
  • Ultrasound in Clinical Applications
  • Apelin-related biomedical research
  • Congenital heart defects research
  • Heart Rate Variability and Autonomic Control
  • Cardiovascular Health and Risk Factors
  • Cardiac Health and Mental Health
  • Advanced Glycation End Products research
  • Sex and Gender in Healthcare
  • Biomarkers in Disease Mechanisms
  • Cardiovascular Effects of Exercise
  • Global Public Health Policies and Epidemiology
  • Viral Infections and Immunology Research
  • Magnesium Alloys: Properties and Applications

Angiologica (Italy)
2024

Association for Symbolic Logic
2020

University of Bari Aldo Moro
2013-2016

The assessment of right ventricular ( RV ) function still remains a challenge. Two‐dimensional (2D) speckle tracking has recently been proposed to evaluate by analyzing myocardial deformation. aim this study was the role 2D systolic strain measures in predicting mortality patients with chronic heart failure HF ). We enrolled 332 outpatients stable clinical condition and conventional therapy. A ventricular–focused four‐chamber view analyzed global longitudinal ‐ GLS free wall ‐fw LS During...

10.1111/echo.13199 article EN Echocardiography 2016-02-11

Aims To evaluate the independent prognostic role of two‐dimensional (2D) strain measures reflecting global longitudinal left ventricular ( LV ) systolic function in outpatients affected by chronic heart failure CHF ). Methods and results Global GLS was assessed 308 , analyzing standard views with 2D speckle tracking technique. During a mean follow‐up 26 ± 13 months 37 patients died (29 due to cardiovascular causes), 10 underwent transplantation, 75 experienced at least 1 episode...

10.1111/echo.12142 article EN Echocardiography 2013-03-14

Many data were published about Long-Covid prevalence, very few the findings of new cardiac alterations (NCA) in COVID-19-recovered people.

10.1016/j.ijcrp.2024.200267 article EN cc-by-nc-nd International Journal of Cardiology Cardiovascular Risk and Prevention 2024-04-05

Galectin-3 (Gal-3) is a novel biomarker reflecting inflammation status and fibrosis involving worsening of both cardiac renal functions.The aim this study was to evaluate the relationship between Gal-3 serum levels microalbuminuria in group chronic heart failure (CHF) outpatients.We enrolled CHF outpatients having stable clinical conditions receiving conventional therapy. All patients underwent evaluation, routine chemistry analysis, echocardiography, evaluation urinary albumin/creatinine...

10.5812/cardiovascmed.28952 article EN cc-by-nc-sa Research in Cardiovascular Medicine 2015-11-24

The renal arterial resistance index (RRI) is a Doppler measure, which reflects abnormalities in the blood flow. aim of this study was to verify value RRI as predictor worsening function (WRF) group chronic heart failure (CHF) outpatients.We enrolled 266 patients stable clinical conditions and on conventional therapy. Peak systolic velocity end diastolic segmental artery were obtained by pulsed flow, calculated. Creatinine serum levels evaluated at baseline 1 year, changes used assess WRF...

10.1159/000448405 article EN Cardiorenal Medicine 2016-09-20

Background: Galectin-3 (Gal-3) is a novel biomarker reflecting inflammation status and fibrosis involving worsening of both cardiac renal functions. Objectives: The aim this study was to evaluate the relationship between Gal-3 serum levels microalbuminuria in group chronic heart failure (CHF) outpatients. Patients Methods: We enrolled CHF outpatients having stable clinical conditions receiving conventional therapy. All patients underwent evaluation, routine chemistry analysis,...

10.4103/2251-9572.218694 article EN cc-by-nc-sa Research in Cardiovascular Medicine 2016-01-01

Chronic heart failure (CHF) represents a major and growing health problem, due to its high incidence prevalence, poor prognosis impact on health-care costs. Although CHF patients are mainly elderly, few studies were aimed at testing the efficacy of diagnostic therapeutic approaches in this population. The difficulty diagnosis among elderly is related different factors, such as: frequent presence co-morbidity conditions mimicking or masking signs symptoms; cut-offs natriuretic peptides; need...

10.3969/j.issn.1671-5411.2013.02.010 article EN PubMed 2013-06-01

In chronic heart failure (CHF) patients there is a wide variability in the minimal effective diuretic dose. The aim of this study to evaluate whether renal resistance index (RRI) associated baseline dose and changes at one year. 250 outpatients stable condition conventional therapy were enrolled. Baseline RRI was calculated by arterial Doppler. total daily loop diuretics assessed after High (HDD) defined as furosemide equivalent > 100 mg. independently with HDD univariate (OR 1.39; 95% CI:...

10.1016/j.ijcha.2015.03.004 article EN cc-by-nc-nd IJC Heart & Vasculature 2015-05-02

Background: Cardiovascular (CV) disease is the leading cause of death in women, but few them are aware CV risks (CVRs). Most women not all risk factorsand their knowledge often still does improve lifestyle. Methods: The Carin Women a survey conducted among Italian by filling out questionnaire waiting rooms clinics. aim was to determine level awareness women’s cardiovascular risk, factors, and A total 5590 questionnaires were completed two different periods. Results: Median age 56 (IQR...

10.3390/jcm13113253 article EN Journal of Clinical Medicine 2024-05-31

In chronic heart failure (CHF) patients, diuretic administration plays a key role in the control of congestion. However, high dose (HDD) has been also demonstrated to be associated worse prognosis. The aim this study was evaluate factors independently HDD and, particular, marker renal perfusion, Renal arterial Resistance Index (RRI). We enrolled 250 outpatients (78% males, 64±13 years, NYHA class 2.2±0.6, left ventricular ejection fraction, LVEF, 34±10%) with CHF (ESC criteria) due systolic...

10.1093/eurheartj/eht307.p636 article EN European Heart Journal 2013-08-02

The aim of this study was to evaluate in a group chronic heart failure (CHF) outpatients whether parameter reflecting renal perfusion (Renal Resistance Index, RRI) could add an incremental prognostic information the standard evaluation dysfunction. We enrolled 250 (78% males, 64±13 years, NYHA class 2.2±0.6, left ventricular ejection fraction, LVEF, 34±10%) with CHF (ESC criteria) due systolic dysfunction, stable clinical conditions (> 1 month) and conventional therapy. Peak velocity end...

10.1093/eurheartj/eht309.p3837 article EN European Heart Journal 2013-08-02

Sex and gender differences change biology pathophysiology. Up to now there has been no attention this problem the results of scientific research conducted mainly in men were inappropriately shifted female sex. The “umbrella-hormone” bias come minimize impact risk factors cardiovascular disease which instead are leading cause death women developed countries. To take stock awareness Italy identify methods topics intervention, ARCA (Associazioni Regionali Cardiology Ambulatoriali), with...

10.17473/1971-6818-2021-1-9 article EN Cardiologia Ambulatoriale 2021-05-30

In chronic heart failure (CHF) patients, renal dysfunction assessed by glomerular filtration rate (GFR) has been demonstrated to be independently associated with higher morbidity and mortality rates. The aim of this study was define whether a novel marker perfusion impairment (Renal Resistance Index, RRI) could play role in predicting progression. We enrolled 250 outpatients (78% males, 64±13 years, NYHA class 2.2±0.6, left ventricular ejection fraction, LVEF, 34±10%) CHF (ESC criteria) due...

10.1093/eurheartj/eht307.p637 article EN European Heart Journal 2013-08-02

Fra le manifestazioni cliniche del COVID, il coinvolgimento dell’apparato cardiovascolare è ad oggi un’evidenza accertata. Sono stati descritti sintomi cardiologici anche ben oltre la fase acuta e dimissione ospedaliera, con quadri clinici variabili che possono perdurare per mesi. Al fine di valutare frequenza tipo danno in pazienti pregresso COVID-19, asintomatico paucisintomatico, A.R.C.A. (Associazioni Regionali Cardiologi Ambulatoriali), ha progettato diffuso tra i suoi associati un...

10.17473/1971-6818-2021-3-5 article IT Cardiologia Ambulatoriale 2022-01-30
Coming Soon ...